
EleCare is owned by Abbott Laboratories (NYSE: ABT), the American health care company headquartered in North Chicago, Illinois. Launched in 2003, EleCare is an amino acid-based hypoallergenic formula for infants and children who cannot tolerate intact or hydrolyzed protein. It is manufactured at Abbott's Sturgis, Michigan facility and was included in the 2022 recall that triggered the US infant formula shortage.
Parent Company
Founded
2003
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| EleCare | Abbott Laboratories | Wholly owned |
EleCare launched in 2003 as Abbott's entry into the amino acid-based formula (AAF) category, making it the second-oldest AAF product in the US market after Nutricia's Neocate, introduced in 1984. Amino acid formulas are the most elemental form of infant nutrition: protein is supplied as individual amino acids rather than intact or partially broken-down proteins, for infants whose systems cannot tolerate even extensively hydrolyzed formulas.
The product line grew to include EleCare for infants and EleCare Jr for children over one year, addressing ongoing protein intolerance, eosinophilic gastrointestinal disorders, and short bowel syndrome in toddlers and older children. Use is typically driven by allergist and gastroenterologist recommendation rather than retail discovery.
EleCare's history became inseparable from Abbott's Sturgis, Michigan facility, its sole US manufacturing site. When the FDA investigation and voluntary recall hit Sturgis in February 2022, EleCare was among the affected products. Because it serves children with the most severe dietary restrictions, EleCare-dependent families faced the most acute version of the national shortage: many of these children have no safe alternative.
Sturgis reopened after remediation, and Abbott invested in additional capacity and redundancy. EleCare returned to distribution, but the 2022 event permanently changed how regulators, clinicians, and parents view single-site production of specialty medical formula. As of 2026 EleCare continues as Abbott's AAF product, marketed under Abbott Nutrition.
What does Abbott Laboratories own?
Abbott Laboratories owns brands across nutrition (Similac, Ensure, PediaSure, Pedialyte), medical devices (FreeStyle Libre, Volt, TactiFlex, Amulet), and diagnostics (Cologuard, BinaxNOW, Alinity). The company acquired Exact Sciences in March 2026 for $21 billion, adding Cologuard and other molecular diagnostic products.
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories trades on the New York Stock Exchange under the ticker symbol ABT. The company has been publicly listed since 1929 and is a component of the S&P 500 Index.
Who founded Abbott Laboratories?
Abbott was founded in 1888 by Dr. Wallace Calvin Abbott, a physician in Ravenswood, Illinois (now part of Chicago). He began by manufacturing reliable dosimetric granules for pharmaceutical use.
Where is Abbott Laboratories headquartered?
Abbott is headquartered in Abbott Park, North Chicago, Illinois, USA. The company operates in more than 160 countries globally.
How many brands does Abbott Laboratories own?
Abbott owns numerous brands across its four segments. Key consumer brands include Similac, Ensure, PediaSure, and Pedialyte in nutrition. Key medical device brands include FreeStyle Libre, Volt, and Amulet. Key diagnostics brands include Cologuard, BinaxNOW, and Alinity.
Who owns Abbott Laboratories?
Abbott Laboratories is a publicly traded company with shares held by institutional investors, mutual funds, and individual shareholders. The company is led by Chairman and CEO Robert B. Ford.
What is Abbott Laboratories' revenue?
Abbott reported Q2 2026 sales of $12.59 billion, up 13.0% on a reported basis and 4.8% on a comparable basis. The company reaffirmed full-year 2026 comparable sales growth guidance of 6.5% to 7.5% and raised adjusted diluted EPS guidance to $5.45 to $5.60.
Did Abbott acquire Exact Sciences?
Yes, Abbott completed the $21 billion acquisition of Exact Sciences in March 2026. The acquisition added Cologuard, a noninvasive colorectal cancer screening test, to Abbott's diagnostics portfolio. Diagnostics sales grew 42% year over year in Q2 2026, the first full quarter including Exact Sciences results.
Abbott reports company-level sustainability commitments including science-based emissions targets and packaging improvement programs. EleCare itself holds no independent third-party sustainability certifications, and Abbott is not a Certified B Corporation.
The brand's ethical dimensions center on access and safety. Because EleCare is medically necessary for its users, insurance coverage decisions and supply interruptions carry ethical weight beyond ordinary consumer products. Abbott states that it works with payers and clinicians to support access.
2022 Sturgis recall: In February 2022, Abbott voluntarily recalled Similac, Alimentum, and EleCare products manufactured at its Sturgis, Michigan plant after FDA investigation found conditions that could allow Cronobacter sakazakii growth. Because EleCare is produced only at Sturgis and serves children with no safe alternatives, the recall produced severe localized shortages for AAF-dependent families. The facility reopened after extensive remediation, and Abbott invested in redundancy measures. Congressional hearings and litigation followed.
Specialty formula market concentration: The 2022 crisis highlighted that amino acid formulas are made at a handful of sites industry-wide. Regulators and clinicians have since pushed for supply diversification and contingency planning for medically necessary formula.
Access and pricing complaints: Families and clinicians have documented difficulty obtaining EleCare when insurers deny coverage or when pharmacies lack stock. These access issues predate the 2022 recall and reflect broader problems in medical nutrition reimbursement rather than a single incident.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Abbott Laboratories | USA | 1973 | Mass market | Global | All-ages | |
| Abbott Laboratories | USA | 1964 | Mass market | United states | All-ages | |
| Abbott Laboratories | USA | 1988 | Mass market | Global | All-ages |
Healthcare PharmaceuticalsOwned by Abbott Laboratories
American adult nutrition shake brand owned by Abbott Laboratories, introduced in 1973 and sold in more than 160 countries as a complete nutritional supplement.
Healthcare PharmaceuticalsOwned by Abbott Laboratories
Oral electrolyte solution brand owned by Abbott Laboratories, first issued to hospitals in 1966 and now marketed to children and adults for hydration.
Baby CareOwned by Abbott Laboratories
Children's nutritional supplement drink brand owned by Abbott Laboratories, launched in 1988 and marketed for children ages 1 to 13 needing supplemental nutrition.
Market Positioning: EleCare competes with 3 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Abbott Laboratories, giving you alternative choices that support different corporate structures.
Baby CareOwned by The Honest Company, Inc.
Consumer goods brand co-founded by Jessica Alba in 2012, focused on non-toxic household and baby products, publicly traded on NASDAQ under ticker HNST.
The Honest Company operates independently without a large parent corporation.
Baby CareOwned by Evyap
Turkish brand of baby care and gentle personal care products manufactured by Evyap, formulated for sensitive infant skin. Sold in over 100 countries across Europe, Asia, the Middle East, and Africa.
Evy Baby is privately owned, unlike EleCare which is under a publicly traded parent company.
Baby CareOwned by Newell Brands Inc.
American brand of premium jogging strollers and baby gear, founded in 1984 by Phil Baechler and owned by Newell Brands (NASDAQ: NWL), sold in over 60 countries worldwide.
Baby Jogger is owned by Newell Brands Inc., offering a different ownership alternative.
Baby CareOwned by Newell Brands Inc.
German baby care brand founded in 1956, specializing in baby bottles, pacifiers, and infant feeding products. Owned by Newell Brands (NASDAQ: NWL) since 2011. Known for orthodontic pacifier designs developed with input from dental professionals. Faced a microplastics class action lawsuit in 2024.
NUK is owned by Newell Brands Inc., offering a different ownership alternative.
Baby CareOwned by Procter & Gamble Company
Baby laundry detergent brand owned by Procter and Gamble. The
Dreft is owned by Procter & Gamble Company, offering a different ownership alternative.
Baby CareOwned by Reckitt
American infant formula brand owned by Reckitt (via Mead Johnson Nutrition), introduced in 1959 and the second-largest infant formula brand in the United States. Known for its NeuroPro formulation and DHA-enriched products.
Enfamil is owned by Reckitt, offering a different ownership alternative.
Discover popular brands and companies in the Baby Care category and related searches from other users.

American brand of premium jogging strollers and baby gear, founded in 1984 by Phil Baechler and owned by Newell Brands (NASDAQ: NWL), sold in over 60 countries worldwide.

Baby laundry detergent brand owned by Procter and Gamble. The

American infant formula brand owned by Reckitt (via Mead Johnson Nutrition), introduced in 1959 and the second-largest infant formula brand in the United States. Known for its NeuroPro formulation and DHA-enriched products.